Being FDA- approved in 2013 after 7 long years of clinical research, the first-ever multi-hour wearable ultrasound device was developed by studying and improving the biophysical effects of ultrasound (US) therapy to quicken soft tissue repair.

The main idea behind this development was the application of the US for many hours, regularly, to enable soft tissue injuries healing utilized by a renowned, FDA cGMP and ISO 13585 medical technology company. 

The Government agencies have invested a significant amount of funding to further clinically confirm this device’s healing effects on back pain, arthritis, and overuse injuries. From the year 2013 to 2020, the wearable device went through extensive acceptance by athletes, plus work-associated injury market areas. It has been sanctioned by several health plans and insurance providers in the United States. As of 2020, this company holds 46 patents worldwide and has offered healing benefits of US therapy to more than 200,000 individuals. The researchers plan to provide the device’s healing power to 100 million people throughout the world in the coming 5 years.